Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 287 for heart disease

Edit search filters
  1. ABSORB III Randomized Controlled Trial (RCT)

    Rochester, MN

  2. Further Cardiovascular Outcomes Research With PCSK9 Inhibition In Subjects With Elevated Risk

    Scottsdale/Phoenix, AZ

  3. A Study To Evaluate The Effectiveness And Safety Of DA-1229 (Evogliptin) In Delaying Progression Of Mild Or Moderate Calcific Aortic Stenosis (EVOID-AS Trial)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate The Effect Of The Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, On Pulmonary Gas Transfer And Respiration In Patients With Congestive Heart Failure

    Rochester, MN

  5. "About Me" Pedigree Tool Pilot

    Rochester, MN

  6. Use of Cardiac Magnetic Resonance Imaging (cMRI) and Echocardiogram to Diagnose Constrictive Pericarditis and Restrictive Cardiomyopathy

    Rochester, MN

  7. A Study Of The Effect Of Dapagliflozin On Symptoms And Biomarkers In Diabetes Patients With Heart Failure

    Rochester, MN

  8. Continued Access To PREVAIL (CAP2)

    Rochester, MN

  9. Cara CDRM (Conduction Disturbance Risk Monitor) 2.0

    Rochester, MN

  10. Healthy Immigrant Community: Mobilizing the Power of Social Networks

    Rochester, MN

.

Mayo Clinic Footer